Clinical trials
Metabolic Diseases trials in Canada with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.A.G.I.C. Clinic LTD | 1 |
| Ottawa Hospital Research Institute | 1 |
| REGENXBIO Inc. | 1 |
| University of British Columbia | 1 |
| University of Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 5 |
| Cardiovascular Diseases | 2 |
| Obesity | 2 |
| Atherosclerosis | 1 |
| Body Weight | 1 |
| Fabry Disease | 1 |
| Fatty Liver | 1 |
| Gaucher Disease | 1 |
| Genetic Diseases, Inborn | 1 |
| Glycogen Storage Disease Type II | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.